As of 2024-12-15, the Relative Valuation of Iteos Therapeutics Inc (ITOS) is (89.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.68 USD, the upside of Iteos Therapeutics Inc based on Relative Valuation is -1262.6%.
The range of the Relative Valuation is (91.48) - (101.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 44.6x | 34.4x |
| Forward P/E multiples | 19.0x - 30.5x | 19.4x |
| Fair Price | (91.48) - (101.17) | (89.29) |
| Upside | -1291.1% - -1417.3% | -1262.6% |
| Date | P/E |
| 2024-12-12 | -2.44 |
| 2024-12-11 | -2.50 |
| 2024-12-10 | -2.48 |
| 2024-12-09 | -2.54 |
| 2024-12-06 | -2.51 |
| 2024-12-05 | -2.41 |
| 2024-12-04 | -2.47 |
| 2024-12-03 | -2.51 |
| 2024-12-02 | -2.58 |
| 2024-11-29 | -2.58 |
| 2024-11-27 | -2.57 |
| 2024-11-26 | -2.47 |
| 2024-11-25 | -2.48 |
| 2024-11-22 | -2.51 |
| 2024-11-21 | -2.45 |
| 2024-11-20 | -2.36 |
| 2024-11-19 | -2.38 |
| 2024-11-18 | -2.37 |
| 2024-11-15 | -2.48 |
| 2024-11-14 | -2.55 |
| 2024-11-13 | -2.66 |
| 2024-11-12 | -2.77 |
| 2024-11-11 | -2.83 |
| 2024-11-08 | -2.79 |
| 2024-11-07 | -2.77 |
| 2024-11-06 | -2.83 |
| 2024-11-05 | -2.78 |
| 2024-11-04 | -2.70 |
| 2024-11-01 | -2.65 |
| 2024-10-31 | -2.55 |
| 2024-10-30 | -2.59 |
| 2024-10-29 | -2.58 |
| 2024-10-28 | -2.69 |
| 2024-10-25 | -2.63 |
| 2024-10-24 | -2.59 |
| 2024-10-23 | -2.67 |
| 2024-10-22 | -2.71 |
| 2024-10-21 | -2.74 |
| 2024-10-18 | -2.84 |
| 2024-10-17 | -2.90 |
| 2024-10-16 | -2.88 |
| 2024-10-15 | -2.84 |
| 2024-10-14 | -2.93 |
| 2024-10-11 | -3.00 |
| 2024-10-10 | -2.73 |
| 2024-10-09 | -2.76 |
| 2024-10-08 | -2.84 |
| 2024-10-07 | -2.95 |
| 2024-10-04 | -3.02 |
| 2024-10-03 | -2.92 |